PDF herunterladen
Semin Neurol 2014; 34(04): 479-480
DOI: 10.1055/s-0034-1394130
Erratum
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cerebral Creatine Deficiencies: A Group of Treatable Intellectual Developmental Disorders

Sylvia Stockler-Ipsiroglu
1   Division of Biochemical Diseases, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada
2   Treatable Intellectual Disability Endeavor in British Columbia (TIDE-BC), University of British Columbia, Vancouver, Canada
3   Child and Family Research Institute, University of British Columbia, Vancouver, Canada
,
Clara D. M. van Karnebeek
1   Division of Biochemical Diseases, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada
2   Treatable Intellectual Disability Endeavor in British Columbia (TIDE-BC), University of British Columbia, Vancouver, Canada
3   Child and Family Research Institute, University of British Columbia, Vancouver, Canada
4   Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. November 2014 (online)

    Lizenzen und Reprints

Originalartikel zu diesem Erratum:

Cerebral Creatine Deficiencies: A Group of Treatable Intellectual Developmental DisordersSemin Neurol 2014; 34(03): 350-356
DOI: 10.1055/s-0034-1386772

The publisher regrets an error in the above article in Seminars in Neurology, Volume 34, Number 3, 2014, page 351 (DOI: 10.1055/s-0034-1386772). [Fig. 1] suggests that ornithine is methylated to produce creatine. However, it is actually guanidinoacetate that is methylated. The correct figure appears below.

Zoom Image
Fig. 1 Creatine synthesis and metabolism. ADP, adenosine-diphosphate; AGAT, arginine: glycine amidinotransferase deficiency; ATP, adenosinetriphosphate; CK, creatine kinase; CRTR, creatine transporter (SLC6A8); GAMT, guanidinoacetate methyltransferase.